BioVie Inc. (BIVI) Ownership
BIVI ownership summary
as of October 18, 2026- Institutions
- 22.1% of shares outstanding
- Insiders
- 0.49% of shares outstanding
- Shares outstanding
- 8.7M
- Float
- 7.5M shares available to trade
- Short interest
- 10.73% 831K shares short
- Days to cover
- 1.95 short interest down 20.5% vs prior month
- Institutions 22.13%
- Insiders 0.49%
- Other investors 77.39%
BIVI top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Morgan Stanley - Brokerage Accounts | 6.97% | 605K | $726,565 | +530,250 (+704.9%) | June 30, 2026 |
| 2 | Diametric Capital, LP | 2.96% | 257K | $307,963 | −113,364 (−30.6%) | June 30, 2026 |
| 3 | Renaissance Technologies Corp | 1.47% | 128K | $153,502 | +60,000 (+88.3%) | June 30, 2026 |
| 4 | Citadel Advisors Llc | 1.11% | 96K | $115,142 | +50,660 (+111.9%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 0.82% | 71K | $85,087 | −13,161 (−15.7%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 0.81% | 71K | $84,902 | −13,451 (−16.0%) | June 30, 2026 |
| 7 | Philadelphia Trust Co | 0.58% | 50K | $60,012 | −25,000 (−33.3%) | June 30, 2026 |
| 8 | Vanguard Fiduciary Trust Co | 0.43% | 38K | $45,068 | — | June 30, 2026 |
| 9 | Jane Street Group LLC | 0.41% | 36K | $43,032 | +13,069 (+57.3%) | June 30, 2026 |
| 10 | Springbok Capital Management, LLC | 0.38% | 33K | $39,100 | −59,480 (−64.6%) | June 30, 2026 |
| 11 | CAMBRIDGE Invest RESEARCH ADVISORS, INC. | 0.32% | 28K | $33,158 | +27,632 (0.0%) | June 30, 2026 |
| 12 | Northern Trust Corp | 0.25% | 22K | $26,184 | +7,631 (+53.8%) | June 30, 2026 |
| 13 | Persistent Asset Partners Limited | 0.17% | 15K | $17,995 | +14,996 (0.0%) | June 30, 2026 |
| 14 | XTX Topco Ltd | 0.16% | 14K | $17,074 | −6,998 (−33.0%) | June 30, 2026 |
| 15 | Caprock Group Inc | 0.13% | 11K | $13,560 | +11,300 (0.0%) | June 30, 2026 |
| 16 | Hanson Mcclain Inc | 0.06% | 5,600 | $6,720 | — | June 30, 2026 |
| 17 | UBS Group AG | 0.03% | 2,175 | $2,610 | +2,169 (+36,150.0%) | June 30, 2026 |
| 18 | Tower Research Capital LLC | 0.02% | 2,064 | $2,477 | −5,476 (−72.6%) | June 30, 2026 |
| 19 | PNC Financial Services Group Inc | 0.01% | 1,000 | $1,200 | — | June 30, 2026 |
| 20 | SBI Securities Co Ltd | 0.01% | 867 | $1,040 | +636 (+275.3%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 718K shares and 7 cut 237K.
BIVI top mutual fund and ETF holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.44% | 38K | $46,189 | −207 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Series Total Market Index | 0.13% | 11K | $13,078 | — | August 31, 2026 |
| 3 | Belfund SICAV Belinvest Equity A USD Acc | 0.12% | 10K | $12,000 | — | August 31, 2026 |
| 4 | Fidelity Nasdaq Composite Index | 0.09% | 7,980 | $9,576 | — | August 31, 2026 |
| 5 | Fidelity Total Market Index | 0.03% | 2,825 | $3,390 | +424 (+17.7%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
BIVI insider transactions
latest 5| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-30 | Cuong V Do | Buy | $17.80 | 1,000 | $17,800 |
| 2023-09-05 | Steve Gorlin | Sell | $30.50 | 856 | $26,108 |
| 2023-08-22 | Richard J Berman | Sell | $35.00 | 1,080 | $37,800 |
| 2023-06-07 | Richard J Berman | Sell | $58.10 | 598 | $34,744 |
| 2023-05-22 | Richard J Berman | Sell | $65.00 | 500 | $32,500 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
BIVI shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns BIVI
Institutional investors own 22.1% of BioVie's shares and insiders 0.49%. The largest holder is Morgan Stanley - Brokerage Accounts with 6.97% of the shares (605K), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 7 reduced their stake in the latest filings. Short interest is 10.73% of the float, or 1.95 days of average trading volume. The share count rose 113,054.3% since 2014.
Related: BIVI analyst forecast, BIVI key metrics. See the BIVI stock overview for the latest quote and news.
BIVI ownership FAQ
Who owns the most BioVie stock?
The largest shareholders of BioVie are Morgan Stanley - Brokerage Accounts (6.97%), Diametric Capital, LP (2.96%), Renaissance Technologies Corp (1.47%), Citadel Advisors Llc (1.11%), Vanguard Capital Management, LLC (0.82%).
What percentage of BioVie is owned by institutions?
Institutions hold 22.1% of BioVie's shares outstanding; insiders hold 0.49%.
Which funds own BioVie?
The largest fund holders of BioVie are Fidelity Extended Market Index (0.44%), Fidelity Series Total Market Index (0.13%), Belfund SICAV Belinvest Equity A USD Acc (0.12%), Fidelity Nasdaq Composite Index (0.09%), Fidelity Total Market Index (0.03%).
What is BioVie's short interest?
831K shares of BioVie were sold short, 10.73% of the float; at the average daily volume it would take 1.95 days to cover.
Are insiders buying or selling BioVie?
Of the latest 5 reported insider transactions in BioVie (since May 22, 2023), 1 were purchases and 4 were sales.
How many shares of BioVie are outstanding?
BioVie has 8.7M shares outstanding, of which 7.5M are in the public float.